Bonesupport Holding AB (publ) (BONEX.ST) Stock Analysis & Winston Score

Bonesupport is a Swedish medical device company that makes injectable bone graft substitutes — materials that help broken or damaged bones heal. Its main product line is called CERAMENT, which is injected into bone voids left after fractures or surgery, then slowly replaced by the patient's own natural bone. Hospitals, orthopedic surgeons, and trauma centers are the primary customers. The company earns revenue by selling its CERAMENT products directly to hospitals and surgical centers, with the United States being its largest and fastest-growing market alongside Europe. Its 92% gross margin reflects the high value placed on a specialized biological product with strong clinical evidence behind it — that data creates a meaningful barrier for competitors trying to enter the space. The key growth driver is continued U.S. market penetration, where adoption of injectable bone substitutes is still expanding, while the main risk is reimbursement pressure from insurers and hospitals pushing back on the cost of premium surgical materials.